Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Dorr

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Cancer & Clinical Oncology|November 1, 1988
Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptideF A Dorr, J G Kuhn, J Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancerW M Stadler, T Kuzel, B Roth, et al.
Current Opinion in Molecular Therapeutics|November 21, 2001
Toward antisense oligonucleotide therapy for cancer: ISIS compounds in clinical developmentJ T Holmlund, B P Monia, T J Kwoh, et al.
Cancer|July 1, 1992
Controversies in the treatment of metastatic prostate cancerD G McLeod, E D Crawford, B A Blumenstein, et al.
Journal of the National Cancer Institute|October 16, 1991
Potential role of tamoxifen in prevention of breast cancerS G Nayfield, J E Karp, L G Ford, et al.
Cancer Research|May 1, 1986
Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibioticF A Dorr, D D Von Hoff, J G Kuhn, et al.
Lung Cancer (Amsterdam, Netherlands)|February 1, 1996
Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancerC Copley-Merriman, J Corral, K King, et al.
Obstetrics and Gynecology|September 1, 1985
Presence of an estrogen-regulated protein in endometrial cancerG W Sledge, I Ramzy, L G Dressler, et al.
Seminars in Oncology|October 11, 1991
National Cancer Institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placeboR C Benson, E D Crawford, M A Eisenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Metastatic bladder cancer: advances in treatmentW M Stadler, T M Kuzel, D Raghavan, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Cancer & Clinical Oncology|November 1, 1988
Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptideF A Dorr, J G Kuhn, J Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancerW M Stadler, T Kuzel, B Roth, et al.
Current Opinion in Molecular Therapeutics|November 21, 2001
Toward antisense oligonucleotide therapy for cancer: ISIS compounds in clinical developmentJ T Holmlund, B P Monia, T J Kwoh, et al.
Cancer|July 1, 1992
Controversies in the treatment of metastatic prostate cancerD G McLeod, E D Crawford, B A Blumenstein, et al.
Journal of the National Cancer Institute|October 16, 1991
Potential role of tamoxifen in prevention of breast cancerS G Nayfield, J E Karp, L G Ford, et al.
Cancer Research|May 1, 1986
Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibioticF A Dorr, D D Von Hoff, J G Kuhn, et al.
Lung Cancer (Amsterdam, Netherlands)|February 1, 1996
Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancerC Copley-Merriman, J Corral, K King, et al.
Obstetrics and Gynecology|September 1, 1985
Presence of an estrogen-regulated protein in endometrial cancerG W Sledge, I Ramzy, L G Dressler, et al.
Seminars in Oncology|October 11, 1991
National Cancer Institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placeboR C Benson, E D Crawford, M A Eisenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Metastatic bladder cancer: advances in treatmentW M Stadler, T M Kuzel, D Raghavan, et al.
Pageof 4